Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19
Crossref DOI link: https://doi.org/10.1007/s15033-021-2738-4
Published Online: 2021-09-10
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Budweiser, Stephan
Text and Data Mining valid from 2021-09-01
Version of Record valid from 2021-09-01
Article History
First Online: 10 September 2021
Free to read: This content has been made available to all.